Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure
- 1 October 2000
- journal article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 136 (4) , 320-327
- https://doi.org/10.1067/mlc.2000.109318
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Elevated circulating levels and cardiac secretion of soluble fas ligand in patients with congestive heart failureThe American Journal of Cardiology, 1999
- PROGNOSTIC SIGNIFICANCE OF SOLUBLE FAS IN THE SERUM OF PATIENTS WITH BLADDER CANCERJournal of Urology, 1998
- Fas and Fas Ligand Expression on Human Peripheral Blood LeukocytesVox Sanguinis, 1998
- The Expression of Genes Modulating Programmed Cell Death in Normal Human Polymorphonuclear NeutrophilsBiochemical and Biophysical Research Communications, 1997
- Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and MacrophagesThe Journal of Experimental Medicine, 1997
- Metalloproteinase-mediated release of human Fas ligand.The Journal of Experimental Medicine, 1995
- Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?Cancer Letters, 1995
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Apoptosis and diseaseThe Lancet, 1993
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991